The spinal needles market is expected to register 7.2% CAGR during the forecast period, 2019 to 2025. The market was valued at approximately USD 207.6 million in 2018.
Spinal needles are medical equipment that is generally used for diagnostic or therapeutic purposes. These needles are inserted into the spinal canal for the collection of cerebrospinal fluid (CSF) for diagnostic testing or drug administration for the treatment of diseases. The sample collected is mainly used for diagnosing diseases related to the central nervous system.
Segmentation
The global spinal needles have been segmented based on type, application, end-user, and region. The global market, based on type, has been segmented into atraumatic needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is expected to be the largest segment, owing to the increasing adoption of the pencil-point needles.
The global market, based on application, has been bifurcated into therapeutic and diagnostic. The therapeutic segment is expected to be largest, in terms of value, due to the increasing prevalence and diagnosis of brain and spinal diseases.
The global market, based on end-user, has been segmented into hospitals & clinics, diagnostic centers, research laboratories, and others. Hospitals and clinics are the largest end-users of spinal needles market. The hospitals & clinics segment is anticipated to hold a major share of the market during the forecast period due to the growing geriatric population and increasing prevalence of neurodegenerative disorders.
Key Players
The key players operating in the global spinal needles market are Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic plc., EXELINT International, Co., Smiths Medical, Stryker Corporation, ARGON MEDICAL, Myco Medical, Cook Medical, and Novo Nordisk A/S.
Global Spinal Needles Market, by Type
Global Spinal Needles Market by Application
Global Spinal Needles Market, by End User